Evolus Statistics
Total Valuation
Evolus has a market cap or net worth of GBP 726.48 million. The enterprise value is 762.89 million.
Market Cap | 726.48M |
Enterprise Value | 762.89M |
Important Dates
The next estimated earnings date is Monday, March 10, 2025.
Earnings Date | Mar 10, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +6.72% |
Shares Change (QoQ) | +0.68% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 50.25M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -18.44 |
EV / Sales | 3.78 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -44.00 |
Financial Position
The company has a current ratio of 2.47, with a Debt / Equity ratio of 22.05.
Current Ratio | 2.47 |
Quick Ratio | 2.13 |
Debt / Equity | 22.05 |
Debt / EBITDA | n/a |
Debt / FCF | -5.59 |
Interest Coverage | -1.73 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -9.93% |
Return on Capital (ROIC) | -18.11% |
Revenue Per Employee | 575,391 |
Profits Per Employee | -128,505 |
Employee Count | 273 |
Asset Turnover | 1.25 |
Inventory Turnover | 4.59 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.05% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +19.05% |
50-Day Moving Average | 12.58 |
200-Day Moving Average | 13.51 |
Relative Strength Index (RSI) | 67.50 |
Average Volume (20 Days) | 4,009 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 8.01 |
Income Statement
In the last 12 months, Evolus had revenue of GBP 185.28 million and -41.38 million in losses. Loss per share was -0.68.
Revenue | 185.28M |
Gross Profit | 129.59M |
Operating Income | -23.55M |
Pretax Income | -41.13M |
Net Income | -41.38M |
EBITDA | -19.60M |
EBIT | -23.55M |
Loss Per Share | -0.68 |
Balance Sheet
The company has 63.44 million in cash and 96.90 million in debt, giving a net cash position of -33.46 million.
Cash & Cash Equivalents | 63.44M |
Total Debt | 96.90M |
Net Cash | -33.46M |
Net Cash Per Share | n/a |
Equity (Book Value) | 4.39M |
Book Value Per Share | 0.07 |
Working Capital | 66.81M |
Cash Flow
In the last 12 months, operating cash flow was -16.41 million and capital expenditures -927,402, giving a free cash flow of -17.34 million.
Operating Cash Flow | -16.41M |
Capital Expenditures | -927,402 |
Free Cash Flow | -17.34M |
FCF Per Share | n/a |
Margins
Gross margin is 69.94%, with operating and profit margins of -12.71% and -22.33%.
Gross Margin | 69.94% |
Operating Margin | -12.71% |
Pretax Margin | -22.20% |
Profit Margin | -22.33% |
EBITDA Margin | -10.58% |
EBIT Margin | -12.71% |
FCF Margin | n/a |
Dividends & Yields
Evolus does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.72% |
Shareholder Yield | -6.72% |
Earnings Yield | -5.70% |
FCF Yield | -2.39% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Evolus has an Altman Z-Score of -0.62. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.62 |
Piotroski F-Score | n/a |